Following the overwhelming evidence that iron deficiency anemia medication Injectafer is unsafe, Pogust Millrood recently submitted the nation’s first lawsuit against the big pharma companies responsible for Injectafer.
On June 15th, the Judicial Panel on Multidistrict Litigation (JPML) issued a report on pending MDL dockets currently active in all U.S. District Courts. The…
In recent years, intravenous iron medication has skyrocketed in popularity in the United States as a means of treatment for those 4.5 million Americans who…
It was not far into the New Year when Ethicon, Inc.—a Johnson & Johnson subsidiary—was named in a hernia mesh lawsuit filed in Idaho by…
Avanir Pharmaceuticals manufactures Nuedexta, a prescription drug medication approved by the Food and Drug Administration (FDA) to treat a rare condition—pseudobulbar affect (PBA)—where sufferers experience…
According to the Centers for Disease Control and Prevention (CDC), about 735,000 people suffer a heart attack each year in the U.S.—making heart disease the…
While the Food and Drug Administration (FDA) is charged with supervising a wide array of public health concerns that include blood transfusions, radiation-emitting devices, tobacco…
Mass tort cases continue to pile up for Johnson & Johnson (J&J) and their subsidiaries. So is the case with Risperdal, a treatment for bipolar…
When Invokana was first approved by the Food and Drug Administration (FDA) in 2013, it commenced a new class of diabetes treatment. Specifically known as…
In December, I wrote a blog discussing the likelihood of MultiDistrict Litigation (MDL) for two manufacturers of a hernia mesh surgical device—Atrium Medical who produces…